Moreover, the 36-month beta value for DCTH is 0.80. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for DCTH is 23.71M and currently, short sellers hold a 6.18% of that float. On September 06, 2024, DCTH’s average trading volume was 267.09K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
DCTH) stock’s latest price update
Delcath Systems Inc (NASDAQ: DCTH)’s stock price has gone decline by -7.76 in comparison to its previous close of 10.45, however, the company has experienced a -10.50% decrease in its stock price over the last five trading days. zacks.com reported 2024-09-02 that DCTH’s study of the CHEMOSAT Hepatic Delivery System shows that the device significantly boosts survival rates in uveal melanoma patients with liver metastases, outperforming systemic therapies.
DCTH’s Market Performance
Delcath Systems Inc (DCTH) has experienced a -10.50% fall in stock performance for the past week, with a 23.74% rise in the past month, and a 44.09% rise in the past quarter. The volatility ratio for the week is 7.62%, and the volatility levels for the past 30 days are at 6.48% for DCTH. The simple moving average for the past 20 days is 9.09% for DCTH’s stock, with a 67.26% simple moving average for the past 200 days.
Analysts’ Opinion of DCTH
Many brokerage firms have already submitted their reports for DCTH stocks, with Craig Hallum repeating the rating for DCTH by listing it as a “Buy.” The predicted price for DCTH in the upcoming period, according to Craig Hallum is $18 based on the research report published on June 28, 2024 of the current year 2024.
Stephens, on the other hand, stated in their research note that they expect to see DCTH reach a price target of $25. The rating they have provided for DCTH stocks is “Overweight” according to the report published on May 14th, 2024.
Canaccord Genuity gave a rating of “Buy” to DCTH, setting the target price at $17 in the report published on July 26th of the previous year.
DCTH Trading at 14.20% from the 50-Day Moving Average
After a stumble in the market that brought DCTH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.93% of loss for the given period.
Volatility was left at 6.48%, however, over the last 30 days, the volatility rate increased by 7.62%, as shares surge +22.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +21.73% upper at present.
During the last 5 trading sessions, DCTH fell by -8.45%, which changed the moving average for the period of 200-days by +302.45% in comparison to the 20-day moving average, which settled at $8.93. In addition, Delcath Systems Inc saw 131.72% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DCTH starting from Aharon Gil, who purchase 26,882 shares at the price of $3.72 back on Mar 19 ’24. After this action, Aharon Gil now owns 1,069,710 shares of Delcath Systems Inc, valued at $100,001 using the latest closing price.
SALAMON STEVEN A J, the Director of Delcath Systems Inc, purchase 26,882 shares at $3.72 during a trade that took place back on Mar 19 ’24, which means that SALAMON STEVEN A J is holding 1,121,025 shares at $100,001 based on the most recent closing price.
Stock Fundamentals for DCTH
Current profitability levels for the company are sitting at:
- -3.04 for the present operating margin
- 0.77 for the gross margin
The net margin for Delcath Systems Inc stands at -4.74. The total capital return value is set at -1.67. Equity return is now at value -2852.05, with -204.97 for asset returns.
Based on Delcath Systems Inc (DCTH), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at -5.62. The debt to equity ratio resting at 1.33. The interest coverage ratio of the stock is 283.86.
Currently, EBITDA for the company is -38.05 million with net debt to EBITDA at 0.26. When we switch over and look at the enterprise to sales, we see a ratio of 21.74. The receivables turnover for the company is 3.17for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.55.
Conclusion
To wrap up, the performance of Delcath Systems Inc (DCTH) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
